CUTISS AG raises CHF 7.25M in Series A financing

20-06-2018 – The startup of the project denovoSkin, CUTISS AG raises CHF 7.25 millions in the Series A financing round.

CUTISS AG’s lead product denovoSkin™ has successfully completed Phase I in pediatric patients and is recruiting in multi-centric Phase II studies financed by Wyss Zurich. This series A financing round is succeeding a CHF 1 million convertible loan previously provided to the company by the UZH Life Sciences Fund, and now converted.

Press release (PDF)

Similar News

12-08-2020

hemotune raises CHF 5.1 million Series A funding

hemotune announced today that its spin-off hemotune AG has successfully closed their 5.1 million Series A funding round. The fundraising aims to advance the development of HemoSystem, a...

Winners of the Top100 Startups Award 2020

09-09-2020

The 100 best startups in Switzerland 2020

denovoSkin's startup CUTISS and Wingtra are at the top of the TOP 100 Swiss Startup Award 2020.

22-09-2020

Voliro closes CHF 2.0 million seed round

Voliro AG, a spin-off from ETH Zurich founded in 2019 and currently accelerated at Wyss Zurich, today announced the closing of a CHF 2.0 million seed round to develop advanced flying inspection...